GlassScriptPhysician profile
Kelsey A Hunter
NPI 1316470537
$778.46
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $566 · 2022: $191 · 2023: $21.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $421.19 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $96.22 | 2021-2022 | |
| Leo Pharma INC. | $72.24 | 2021-2022 | |
| Lilly USA, LLC | $39.71 | 2021 | |
| Ucb, INC. | $30.75 | 2021 | |
| Incyte Corporation | $23.43 | 2021 | |
| Arcutis Biotherapeutics, INC. | $21.58 | 2023 | |
| Genzyme Corporation | $20.13 | 2021 | |
| Pfizer INC. | $19.44 | 2021 | |
| Sun Pharmaceutical Industries INC. | $18.20 | 2021 | |
| Amgen INC. | $15.57 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.